Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05893498 · ClinicalTrials.gov registry record · NA

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

A NA study of Percutaneous Coronary Intervention, sponsored by CathWorks.

Active
Registry status
NA
Development phase
1,924
Enrollment target
20
Study locations

NCT05893498 is a NA study of Percutaneous Coronary Intervention that is active but no longer recruiting, run by CathWorks. The registered enrollment target is 1,924 participants, below the 5,065-participant average among 12 other Percutaneous Coronary Intervention trials with a reported enrollment target (62% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05893498, a NA study of Percutaneous Coronary Intervention, is active but no longer recruiting, sponsored by CathWorks.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,924 participants
Enrollment target
20
Study locations

Study Summary

To test whether FFRangio-guided treatment is non-inferior to conventional pressure wire-guided treatment in patients with coronary artery disease.

Conditions Studied

Percutaneous Coronary Intervention

Interventions

  • DEVICE FFRangio
  • DEVICE FFR or NHPR

Study Locations (20)

California

  • University of California San Diego Health - La Jolla
  • VA- Long Beach Healthcare - Long Beach
  • Keck Medicine of USC - Los Angeles
  • UCLA Medical Center - Los Angeles
  • Stanford University - Palo Alto
  • VA - Palo Alto Healthcare - Palo Alto
  • Kaiser Permanente San Francisco - San Francisco
  • St. Joesph's Medical Center - Stockton

Florida

  • HCA Florida JFK Hospital - Atlantis
  • Cardiac & Vascular Institute - Gainesville
  • University of Miami - Miami
  • HCA Florida Northside Hospital - St. Petersburg
  • Tallahassee Research Institute - Tallahassee
  • University of South Florida - Tampa

Kansas

  • Ascension Via Christi St. Francis - Wichita
  • Kansas Heart Hospital - Wichita

Georgia

  • Archbold Hospital - Thomasville

Illinois

  • Carle Foundation Hospital - Urbana

Kentucky

  • St. Elizabeth Healthcare - Edgewood

Maryland

  • Medstar Union Memorial Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 1,924 participants
Start Date 2023-06-21
Est. Completion 2026-05
Phase NA

Sponsor

CathWorks

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05893498

The ClinicalTrials.gov registry entry for NCT05893498 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,924 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,065-participant average among 12 other Percutaneous Coronary Intervention trials with a reported enrollment target (62% lower). The listed sponsor is CathWorks, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Percutaneous Coronary Intervention appearing as the primary indexed condition, and to 2 interventions - of which FFRangio is the first listed.

NCT05893498 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Kansas.

Frequently Asked Questions

What is clinical trial NCT05893498 about?

NCT05893498 is a clinical study titled "Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment". To test whether FFRangio-guided treatment is non-inferior to conventional pressure wire-guided treatment in patients with coronary artery disease.

What is the current status of trial NCT05893498?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,924 participants. The study started on 2023-06-21. Estimated completion is 2026-05.

What conditions does trial NCT05893498 study?

This clinical trial studies the following conditions: Percutaneous Coronary Intervention.

What interventions are being tested in trial NCT05893498?

The interventions under investigation include: FFRangio (DEVICE), FFR or NHPR (DEVICE).

Who is sponsoring clinical trial NCT05893498?

This trial is sponsored by CathWorks, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05893498 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Percutaneous Coronary Intervention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Percutaneous Coronary Intervention

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.